![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2018
Anzahl der Publikationen: 3
2018
Iniguez, Amanda Balboni; Stolte, Björn; Wang, Emily Jue; Conway, Amy Saur; Alexe, Gabriela; Dharia, Neekesh V.; Kwiatkowski, Nicholas; Zhang, Tinghu; Abraham, Brian J.; Mora, Jaume; Kalev, Peter; Leggett, Alan; Chowdhury, Dipanjan; Benes, Cyril H.; Young, Richard A.; Gray, Nathanael S. und Stegmaier, Kimberly
(2018):
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma.
In: Cancer Cell, Bd. 33, Nr. 2: S. 202-216
Iniguez, Amanda Balboni; Alexe, Gabriela; Wang, Emily Jue; Roti, Giovanni; Pate, Sarvagna; Chen, Liying; Kitara, Samuel; Conway, Amy; Robichaud, Amanda L.; Stolte, Björn; Bandopadhayay, Pratiti; Goodale, Amy; Pantel, Sasha; Lee, Yenarae; Cheff, Dorian M.; Hall, Matthew D.; Guha, Rajarshi; Davis, Mindy; Menard, Marie; Nasholm, Nicole; Weiss, William A.; Qi, Jun; Beroukhim, Rameen; Piccioni, Federica; Johannessen, Cory und Stegmaier, Kimberly
(2018):
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling.
In: Cancer Cell, Bd. 34, Nr. 6: S. 922-938
Stolte, Björn; Iniguez, Amanda Balboni; Dharia, Neekesh V.; Robichaud, Amanda L.; Conway, Amy Saur; Morgan, Ann M.; Alexe, Gabriela; Schauer, Nathan J.; Liu, Xiaoxi; Bird, Gregory H.; Tsherniak, Aviad; Vazquez, Francisca; Buhrlage, Sara J.; Walensky, Loren D. und Stegmaier, Kimberly
(2018):
Genome-scale CRISPR-Cas9 screen identifies
druggable dependencies in TP53 wild-type Ewing sarcoma.
In: Journal of Experimental Medicine, Bd. 215, Nr. 8: S. 2137-2155